首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer journal

缩写:CANCER J

ISSN:1528-9117

e-ISSN:1540-336X

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1187条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Michael A Postow,Richard D Carvajal Michael A Postow
Melanoma is a heterogeneous disease representing distinct biologic and genetic subsets. Activating mutations in KIT have been discovered in a significant proportion of melanomas arising from acral, mucosal, and chronically sun-damaged sites...
Fergal C Kelleher,Grant A McArthur Fergal C Kelleher
Cutaneous melanomas have mutations in the NRAS GTPase in 15% of cases. Compared to melanomas with BRAF mutations, or melanomas "wild-type" for BRAF and NRAS, melanomas with NRAS mutations are more likely to be thicker tumors and to have a h...
Ragini Kudchadkar,Kim H T Paraiso,Keiran S M Smalley Ragini Kudchadkar
The discovery of activating BRAF mutations in ∼50% of all melanomas has proved to be a turning point in the therapeutic management of the disseminated disease. In this commentary, we review the latest research delineating the role of mutan...
Melissa Ann Wilson,Katherine L Nathanson Melissa Ann Wilson
Melanoma is the deadliest form of skin cancer and is increasing in incidence. Recent treatment advances have been made, but there remains a need for continued development of effective therapy options, as treatment rarely leads to cure. Many...
Siyuan Zheng,Milan G Chheda,Roel G W Verhaak Siyuan Zheng
Glioblastoma multiforme is a histopathologically heterogeneous disease with few treatment options. Therapy based on genomic alterations is rapidly gaining popularity because of the high response rate and high specificity. DNA copy number an...
Edjah Kweku-Ebura Nduom,Costas George Hadjipanayis,Erwin G Van Meir Edjah Kweku-Ebura Nduom
Glioblastoma remains one of the deadliest forms of cancer. Infiltrating cancer cells in the surrounding brain prevent complete resection, and tumor cell resistance to chemoradiation results in the poor prognosis of the glioblastoma (GBM) pa...
Jiangbing Zhou,Kofi-Buaku Atsina,Benjamin T Himes et al. Jiangbing Zhou et al.
Brain tumors--particularly glioblastoma multiforme--pose an important public health problem in the United States. Despite surgical and medical advances, the prognosis for patients with malignant gliomas remains grim: current therapy is insu...
Ahmed Mohyeldin,Ennio Antonio Chiocca Ahmed Mohyeldin
Progress in improving the prognosis of patients with glioblastoma has been modest and has predominantly relied on informative imaging, optimization of medical and surgical treatment, and approval of new drugs with modest benefits on overall...
Guido Wollmann,Koray Ozduman,Anthony N van den Pol Guido Wollmann
Twenty years of oncolytic virus development have created a field that is driven by the potential promise of lasting impact on our cancer treatment repertoire. With the field constantly expanding-more than 20 viruses have been recognized as ...